EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy

Mohammed Khaled Al Alaili

Precision Medication · 2026-06 · 3 (2) · 100098

DOI: 10.1016/j.prmedi.2026.100098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Medication, 2026-06. Verfasst von Mohammed Khaled Al Alaili. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alaili, M. K. A. (2026). Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy. Precision Medication, 3(2), 100098. https://doi.org/10.1016/j.prmedi.2026.100098

Vancouver

Alaili MKA. Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy. Precision Medication. 2026;3(2):100098. doi:10.1016/j.prmedi.2026.100098

BibTeX
@article{Alaili2026,
  author = {Alaili, Mohammed Khaled Al},
  title = {Gut dysbiosis: An overlooked pharmacokinetic modifier in psychotropic therapy},
  journal = {Precision Medication},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {100098},
  doi = {10.1016/j.prmedi.2026.100098}
}
Kostenlos starten →